INTELLIGENT BIO SOLUTIONS INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INTELLIGENT BIO SOLUTIONS INC. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $8.91M, a 1288.09% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $3.16M.
- INTELLIGENT BIO SOLUTIONS INC. stock issued during period, value, new issues for the quarter ending 2024-12-31 was $642.11K.
- INTELLIGENT BIO SOLUTIONS INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $34.51K.
- INTELLIGENT BIO SOLUTIONS INC. stock issued during period, value, new issues for fiscal 2026 was $8.91M, a 93.56% increase from fiscal 2025.
- INTELLIGENT BIO SOLUTIONS INC. stock issued during period, value, new issues for fiscal 2025 was $4.60M.
- INTELLIGENT BIO SOLUTIONS INC. stock issued during period, value, new issues for fiscal 2023 was $162.46K.
- INTELLIGENT BIO SOLUTIONS INC. stock issued during period, value, new issues for fiscal 2021 was $21.60M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $8.91M 10-K · filed 2026-08-19 | |
| 2025-12-31 | $8.91M 10-Q · filed 2026-05-13 | |
| 2025-06-30 | $4.60M 10-K · filed 2025-08-15 | |
| 2025-03-31 | $3.16M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $642.11K 10-Q · filed 2025-05-13 | |
| 2024-09-30 | $34.51K 10-Q · filed 2025-11-12 | |
| 2023-06-30 | $162.46K 10-K · filed 2024-09-18 | |
| 2022-12-31 | $162.46K 10-Q · filed 2024-05-08 | |
| 2021-06-30 | $21.60M 10-K · filed 2022-09-22 | |
| 2020-12-31 | $21.60M 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |